AbbVie ends a six-day losing streak with a 0.88% gain, though concerns over increased R&D costs and earnings revisions continue to weigh on investor sentiment.
In the last year, many AbbVie Inc. ( NYSE:ABBV ) insiders sold a substantial stake in the company which may have...
AbbVie (ABBV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.